| manager |
|
| language |
- |
| license |
- |
| created at |
2017-12-21 11:07:16 UTC |
| updated at |
2017-12-21 12:22:32 UTC |
|
2 layers
|
143,100 entries
|
There is 0 pattern entry.
|
Drug Product: Description Of Manufacturing Process And Process Controls
|
CONC:NCI_FDA |
|
|
Manufacturing Process Development
|
CONC:NCI_FDA |
|
|
Meeting Background Materials
|
CONC:NCI_FDA |
|
|
Meeting Request
|
CONC:NCI_FDA |
|
|
Analytical Methods And Validation Reports
|
CONC:NCI_FDA |
|
|
Annotated Comparison With Listed Drug
|
CONC:NCI_FDA |
|
|
Annotated Draft Labeling Text
|
CONC:NCI_FDA |
|
|
Annual Report Transmittal: FDA Form 2252
|
CONC:NCI_FDA |
|
|
Form FDA 2252: Transmittal of Annual Reports for Drugs and Biologics for Human Use
|
CONC:NCI_FDA |
|
|
Appendices: Novel Excipients
|
CONC:NCI_FDA |
|
|
Application Form: FDA Form 1571
|
CONC:NCI_FDA |
|
|
Form FDA 1571: Investigational New Drug Application (IND)
|
CONC:NCI_FDA |
|
|
Form FDA 356h: Application to Market a New Drug, Biologic, or an Antibiotic Drug for Human Use
|
CONC:NCI_FDA |
|
|
Application Form: FDA Form 356h
|
CONC:NCI_FDA |
|
|
Approved Labeling Text For Listed Drug
|
CONC:NCI_FDA |
|
